Cosmina M.
- Country
- Romania
- Department
- Psihiatrie III
Research Overview
- Long-term Safety Evaluation of Iclepertin in Schizophrenia Patients Post-Completion of Phase III Trials
- Evaluation of Vafidemstat on Negative Symptoms and Cognitive Impairment in Adult Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial
- Long-Term Safety and Tolerability Assessment of Trospium Chloride and Xanomeline Tartrate in Psychosis Associated with Alzheimer's Disease
Data & Insights
Has run more than one trial at 83 of 207 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in treating psychosis associated with Alzheimer's Disease, focusing on innovative therapeutic approaches for managing behavioral symptoms in elderly patients.
- Alzheimer's Disease Psychosis
- Neuropsychiatric Symptoms
- Cognitive Decline Management
Particular attention is given to evaluating treatment responses using specialized clinical assessment tools.
Psychiatric Disorders
The investigator has dedicated expertise in treating schizophrenia, with particular emphasis on addressing cognitive impairment associated with the condition.
- Cognitive Function
- Long-term Treatment Safety
- Therapeutic Monitoring
Focus includes evaluation of extended treatment outcomes and safety profiles in psychiatric interventions.
Clinical Assessment
The investigator employs specialized assessment methodologies including the Neuropsychiatric Inventory-Clinician (NPI-C) scale for evaluating treatment efficacy.
- Hallucinations Assessment
- Delusions Monitoring
- Behavioral Symptoms Evaluation
Expertise in utilizing standardized clinical measurement tools for psychiatric symptom assessment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.